6'SL (6´Sialyllactose Sodium Salt) is a highly abundant sialylated HMO in human milk. Some primary known benefits of 6SL include the support of brain development by affecting cognition and regulation of neurons. Also, 6'SL can positively support gut health by promoting intestinal epithelial cell maturation.
Regulatory filings for 6'SL have been made in EU and US and preparation on way for other major markets.
GlyCare™ 6SL will be commercially available from 2020.
HMO help support immunity. Clinical studies have reported a relationship between HMO and immune outcomes in infants. HMO are reported to support an infant’s immune system. HMO may help reduce the risk of infection. HMO may help reduce the risk of certain infections in infants.
Clinical and preclinical studies report that HMOs support the growth of beneficial bacteria which are believed to have a role in intestinal development and gut health of an infant. Preclinical studies suggest a potential role for 6’SL in gut health via its support of the growth of beneficial bacteria (3,4,5).
Regulatory filings for 6'SL have been made in EU and US and preparation on way for other major markets.
GlyCare™ 6SL will be commercially available from 2020.
Emerging data from pre-clinical models and breast milk studies suggest that HMOs may play a role reducing the incidence of certain allergic manifestations.
Taste, texture & health. You can have it all.
Solutions to address consumers' health and lifestyle needs.
Science-based expertise supporting innovations that meet consumer needs.
Bright science. Brighter living.™
Explore new science, consumer insights, industry events and more.
Request samples, place orders and view product documentation.
